2 天之前 · With BCG treatment, your healthcare provider delivers immunotherapy drugs directly to your bladder through a catheter. Unlike oral or injectable drugs, BCG treatment targets cancer cells inside of your bladder without having a negative impact on the rest of your body. BCG treatment is the main immunotherapy used to treat early-stage bladder cancer.

2024年4月4日 · BCG, when used intravesicularly for treatment of bladder carcinoma in situ, is thought to cause a local, chronic inflammatory response involving macrophage and leukocyte infiltration of the bladder. BCG (intravesical) is active immunotherapy which stimulates the host's immune mechanism to reject the tumor. Use: Labeled Indications

2023年5月23日 · TheraCys®, BCG Live (Intravesical) contains live, attenuated mycobacteria. Because of the potential risk for transmission, prepare, handle, and dispose of TheraCys as a biohazard material. BCG is capable of dissemination when administered by the intravesical route.

2024年7月14日 · If you’re diagnosed with early-stage bladder cancer, your doctor might recommend a treatment called Bacillus Calmette-Guerin (BCG) therapy. BCG is used to stop the growth of bladder cancer and keep it from returning.

2025年3月1日 · Bacillus Calmette-Guérin (BCG) is used as a solution that is run through a tube (instilled through a catheter) into the bladder to treat bladder cancer. The exact way it works against cancer is not known, but it may work by stimulating the body's immune system.

2024年10月2日 · BCG (Bacillus Calmette-Guérin) therapy, originally developed as a tuberculosis vaccine, continues to be an effective treatment for bladder cancer. BCG is a form of immunotherapy treatment that stimulates the body’s own immune system to fight cancer cells in the bladder. What is BCG?

What is this drug used for? It is used to treat or prevent certain types of bladder cancer. What do I need to tell my doctor BEFORE I take this drug? If you are allergic to this drug; any part of this drug; or any other drugs, foods, or substances. Tell …

Intravesical TICE® BCG has been used as a therapy for, and prophylaxis against, recurrent tumors in patients with carcinoma in situ (CIS) of the urinary bladder, and to prevent recurrence of...

2020年7月17日 · For people with early-stage bladder cancer, an immunotherapy called BCG has been the standard treatment for more than 30 years. It was approved by the FDA in 1990 — it was, in fact, the first ever cancer immunotherapy to be approved — yet scientists still don’t fully understand why the treatment works.

2024年10月29日 · Detailed dosage guidelines and administration information for TICE BCG (bacillus calmette-guerin). Includes dose adjustments, warnings and precautions.